Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients
View ORCID ProfileJacopo Sabbatinelli, View ORCID ProfileAngelica Giuliani, View ORCID ProfileGiulia Matacchione, View ORCID ProfileSilvia Latini, View ORCID ProfileNoemi Laprovitera, View ORCID ProfileGiovanni Pomponio, Alessia Ferrarini, View ORCID ProfileSilvia Svegliati Baroni, Marianna Pavani, Marco Moretti, View ORCID ProfileArmando Gabrielli, View ORCID ProfileAntonio Domenico Procopio, View ORCID ProfileManuela Ferracin, View ORCID ProfileMassimiliano Bonafè, View ORCID ProfileFabiola Olivieri
doi: https://doi.org/10.1101/2020.07.11.20151365
